Danaher (DHR) Stock Forecast, Price Target & Predictions
DHR Stock Forecast
Danaher stock forecast is as follows: an average price target of $283.86 (represents a 26.88% upside from DHR’s last price of $223.73) and a rating consensus of 'Buy', based on 23 wall street analysts offering a 1-year stock forecast.
DHR Price Target
DHR Analyst Ratings
Buy
Danaher Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jan 15, 2025 | Matthew Sykes | Goldman Sachs | $250.00 | $237.97 | 5.06% | 11.74% |
Dec 19, 2024 | Subbu Nambi | Guggenheim | $275.00 | $228.66 | 20.27% | 22.92% |
Oct 31, 2024 | Doug Schenkel | Wolfe Research | $285.00 | $242.32 | 17.61% | 27.39% |
Oct 23, 2024 | Paul Knight | KeyBanc | $310.00 | $257.67 | 20.31% | 38.56% |
Oct 23, 2024 | Catherine Schulte | Robert W. Baird | $277.00 | $261.28 | 6.02% | 23.81% |
Oct 23, 2024 | Puneet Souda | Leerink Partners | $275.00 | $261.28 | 5.25% | 22.92% |
Oct 01, 2024 | Jacob Johnson | Stifel Nicolaus | $315.00 | $273.63 | 15.12% | 40.79% |
Apr 23, 2024 | Justin Bowers | Deutsche Bank | $270.00 | $236.08 | 14.37% | 20.68% |
Apr 17, 2024 | Rajesh Kumar | HSBC | $280.00 | $240.34 | 16.50% | 25.15% |
Sep 27, 2023 | Paul Knight | Loop Capital Markets | $300.00 | $247.44 | 21.24% | 34.09% |
Jan 05, 2023 | Credit Suisse | $300.00 | $266.37 | 12.63% | 34.09% | |
Dec 14, 2022 | Deutsche Bank | $310.00 | $276.68 | 12.04% | 38.56% | |
Nov 29, 2022 | Barclays | $277.00 | $261.16 | 6.07% | 23.81% | |
Jul 31, 2022 | Elizabeth Garcia | UBS | $297.00 | $291.47 | 1.90% | 32.75% |
Jun 01, 2022 | Deane Dray | RBC Capital | $310.00 | $261.83 | 18.40% | 38.56% |
May 06, 2022 | Catherine Schulte | Robert W. Baird | $319.00 | $248.15 | 28.55% | 42.58% |
Apr 29, 2022 | Timothy Daley | Wells Fargo | $265.00 | $257.50 | 2.91% | 18.45% |
Apr 27, 2022 | Deane Dray | RBC Capital | $299.00 | $250.98 | 19.13% | 33.64% |
Feb 06, 2022 | Catherine Schulte | Robert W. Baird | $334.00 | $287.63 | 16.12% | 49.29% |
Jan 30, 2022 | Matthew Sykes | Goldman Sachs | $360.00 | $281.11 | 28.06% | 60.91% |
Jan 16, 2022 | Brendan Luecke | Bernstein | $365.00 | $293.31 | 24.44% | 63.14% |
Oct 22, 2021 | Daniel Brennan | Cowen & Co. | $360.00 | $312.90 | 15.05% | 60.91% |
Oct 22, 2021 | Paul Knight | KeyBanc | $345.00 | $312.90 | 10.26% | 54.20% |
Sep 10, 2021 | Katie Tryhane | Credit Suisse | $370.00 | $329.26 | 12.37% | 65.38% |
Jul 23, 2021 | Derik De Bruin | Bank of America Securities | $340.00 | $290.62 | 16.99% | 51.97% |
Jul 16, 2021 | Robert Wasserman | Benchmark Co. | $330.00 | $284.16 | 16.13% | 47.50% |
Jun 18, 2021 | Erin Wright | Morgan Stanley | $288.00 | $256.20 | 12.41% | 28.73% |
Jun 18, 2021 | Liza Garcia | Wolfe Research | $325.00 | $256.20 | 26.85% | 45.26% |
Danaher Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 3 | 9 |
Avg Price Target | $250.00 | $270.00 | $281.89 |
Last Closing Price | $223.73 | $223.73 | $223.73 |
Upside/Downside | 11.74% | 20.68% | 26.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jan 15, 2025 | Goldman Sachs | Neutral | Neutral | Hold |
Dec 19, 2024 | Guggenheim | Buy | Initialise | |
Oct 23, 2024 | Raymond James | Outperform | Outperform | Hold |
Oct 23, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Oct 23, 2024 | Stephens | Underperform | Underperform | Hold |
Oct 23, 2024 | Cowen & Co. | Buy | Buy | Hold |
Oct 23, 2024 | KeyBanc | Overweight | Overweight | Hold |
Oct 23, 2024 | Leerink Partners | Outperform | Outperform | Hold |
Oct 23, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
Oct 22, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Oct 22, 2024 | William Blair | Outperform | Outperform | Hold |
Oct 01, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Sep 30, 2024 | Stephens | Overweight | Initialise | |
Aug 27, 2024 | Wells Fargo | Overweight | Equal-Weight | Initialise |
Jul 24, 2024 | Cowen & Co. | Buy | Buy | Hold |
Jul 24, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
Jul 23, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Apr 24, 2024 | Cowen & Co. | Buy | Buy | Hold |
Apr 23, 2024 | Deutsche Bank | Buy | Buy | Hold |
Apr 16, 2024 | HSBC | Buy | Upgrade | |
Feb 01, 2024 | Needham | Overweight | Overweight | Hold |
Jan 31, 2024 | Raymond James | Outperform | Outperform | Hold |
Jan 31, 2024 | RBC Capital | Outperform | Outperform | Hold |
Oct 25, 2023 | Citigroup | Buy | Buy | Hold |
Oct 25, 2023 | Raymond James | Outperform | Outperform | Hold |
Oct 25, 2023 | RBC Capital | Outperform | Outperform | Hold |
Sep 27, 2023 | KeyBanc | Overweight | Overweight | Hold |
Sep 27, 2023 | Goldman Sachs | Buy | Buy | Hold |
Sep 27, 2023 | Deutsche Bank | Buy | Buy | Hold |
Sep 27, 2023 | Citigroup | Neutral | Neutral | Hold |
Sep 27, 2023 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
Apr 26, 2023 | Credit Suisse | Neutral | Neutral | Hold |
Apr 18, 2023 | Wedbush | Outperform | Upgrade | |
Apr 18, 2023 | Citigroup | Buy | Upgrade | |
Apr 18, 2023 | Morgan Stanley | Equal-Weight | Upgrade | |
Apr 18, 2023 | BTIG | Neutral | Downgrade | |
Apr 18, 2023 | Wolfe Research | Outperform | Upgrade | |
Apr 18, 2023 | Wells Fargo | Overweight | Upgrade | |
Apr 04, 2023 | Barclays | Overweight | Overweight | Hold |
Jan 05, 2023 | Credit Suisse | Neutral | Downgrade | |
Dec 14, 2022 | Deutsche Bank | Buy | Initialise | |
Nov 29, 2022 | Barclays | Overweight | Overweight | Hold |
Jul 31, 2022 | UBS | Buy | Initialise | |
Jun 01, 2022 | RBC Capital | Outperform | Sector Perform | Upgrade |
Jun 01, 2022 | RBC Capital | Sector Perform | Outperform | Upgrade |
Apr 27, 2022 | RBC Capital | Sector Perform | Sector Perform | Hold |
Apr 26, 2022 | William Blair | Outperform | Outperform | Hold |
Apr 25, 2022 | Zacks Investment Research | Hold | Downgrade | |
Jan 30, 2022 | Goldman Sachs | Buy | Buy | Hold |
Jan 16, 2022 | Bernstein | Outperform | Initialise |
Danaher Financial Forecast
Danaher Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $3.78B | - | $7.16B | $7.17B | $8.37B | $7.66B | $7.75B | $7.69B | $8.15B | $7.23B | $7.22B | $6.86B | $6.76B | $5.88B | $5.30B | $4.34B | $2.84B | $5.04B |
Avg Forecast | $7.25B | $6.35B | $6.36B | $6.32B | $6.78B | $5.95B | $5.93B | $5.89B | $6.44B | $5.59B | $5.59B | $5.62B | $6.13B | $6.60B | $7.12B | $7.04B | $7.90B | $7.16B | $7.30B | $7.55B | $7.92B | $7.00B | $6.72B | $6.29B | $6.58B | $5.51B | $4.95B | $4.32B | $4.80B | $5.02B |
High Forecast | $7.53B | $6.60B | $6.61B | $6.57B | $7.05B | $6.18B | $6.16B | $6.08B | $6.51B | $5.59B | $5.59B | $5.62B | $6.46B | $7.12B | $7.39B | $7.31B | $8.07B | $7.16B | $7.30B | $7.55B | $7.92B | $7.00B | $6.72B | $6.29B | $6.58B | $5.51B | $4.95B | $4.32B | $4.80B | $5.02B |
Low Forecast | $6.99B | $6.12B | $6.14B | $6.10B | $6.54B | $5.74B | $5.72B | $5.68B | $6.39B | $5.58B | $5.59B | $5.62B | $6.02B | $5.36B | $6.86B | $6.79B | $7.65B | $7.16B | $7.30B | $7.55B | $7.92B | $7.00B | $6.72B | $6.29B | $6.58B | $5.51B | $4.95B | $4.32B | $4.80B | $5.02B |
# Analysts | 7 | 5 | 5 | 9 | 5 | 4 | 4 | 11 | 11 | 5 | 4 | 6 | 8 | 18 | 12 | 9 | 8 | 14 | 8 | 8 | 17 | 9 | 11 | 17 | 9 | 13 | 17 | 9 | 8 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.62% | - | 1.01% | 1.02% | 1.06% | 1.07% | 1.06% | 1.02% | 1.03% | 1.03% | 1.07% | 1.09% | 1.03% | 1.07% | 1.07% | 1.00% | 0.59% | 1.00% |
Forecast
Danaher EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 5 | 5 | 9 | 5 | 4 | 4 | 11 | 11 | 5 | 4 | 6 | 8 | 18 | 12 | 9 | 8 | 14 | 8 | 8 | 17 | 9 | 11 | 17 | 9 | 13 | 17 | 9 | 8 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $1.34B | - | $1.46B | $2.40B | $2.26B | $2.58B | $2.77B | $2.15B | $2.73B | $2.00B | $2.72B | $2.64B | $2.12B | $1.59B | $1.78B | $1.06B | $1.67B | $1.19B |
Avg Forecast | $2.20B | $1.92B | $1.93B | $1.92B | $2.06B | $1.80B | $1.80B | $1.78B | $1.95B | $1.69B | $1.69B | $1.80B | $1.86B | $2.00B | $2.16B | $1.64B | $2.40B | $2.20B | $2.25B | $1.30B | $2.57B | $2.16B | $2.07B | $1.94B | $2.03B | $1.70B | $1.52B | $1.03B | $1.48B | $1.55B |
High Forecast | $2.28B | $2.00B | $2.00B | $1.99B | $2.14B | $1.87B | $1.87B | $1.84B | $1.97B | $1.69B | $1.69B | $2.17B | $1.96B | $2.16B | $2.24B | $1.97B | $2.88B | $2.20B | $2.25B | $1.56B | $3.08B | $2.16B | $2.07B | $1.94B | $2.03B | $1.70B | $1.52B | $1.23B | $1.48B | $1.55B |
Low Forecast | $2.12B | $1.86B | $1.86B | $1.85B | $1.98B | $1.74B | $1.73B | $1.72B | $1.93B | $1.69B | $1.69B | $1.44B | $1.82B | $1.62B | $2.08B | $1.31B | $1.92B | $2.20B | $2.25B | $1.04B | $2.05B | $2.16B | $2.07B | $1.94B | $2.03B | $1.70B | $1.52B | $820.19M | $1.48B | $1.55B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.72% | - | 0.68% | 1.46% | 0.94% | 1.17% | 1.23% | 1.66% | 1.06% | 0.93% | 1.31% | 1.36% | 1.05% | 0.94% | 1.17% | 1.03% | 1.13% | 0.77% |
Forecast
Danaher Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 5 | 5 | 9 | 5 | 4 | 4 | 11 | 11 | 5 | 4 | 6 | 8 | 18 | 12 | 9 | 8 | 14 | 8 | 8 | 17 | 9 | 11 | 17 | 9 | 13 | 17 | 9 | 8 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $1.08B | - | $1.11B | $1.45B | $2.23B | $1.57B | $1.68B | $1.73B | $1.79B | $1.16B | $1.78B | $1.70B | $1.24B | $883.50M | $927.30M | $595.10M | $1.28B | $668.00M |
Avg Forecast | $1.99B | $1.49B | $1.53B | $1.60B | $1.72B | $1.36B | $1.37B | $1.43B | $1.57B | $1.14B | $1.15B | $1.02B | $1.40B | $1.32B | $1.30B | $924.29M | $1.57B | $1.49B | $1.55B | $730.66M | $1.68B | $1.42B | $1.35B | $1.16B | $1.24B | $896.46M | $719.99M | $577.60M | $821.70M | $755.19M |
High Forecast | $2.09B | $1.56B | $1.60B | $1.68B | $1.81B | $1.43B | $1.44B | $1.52B | $1.60B | $1.14B | $1.15B | $1.22B | $1.46B | $1.51B | $1.36B | $1.11B | $1.89B | $1.49B | $1.55B | $876.79M | $2.02B | $1.42B | $1.35B | $1.16B | $1.24B | $896.46M | $719.99M | $693.12M | $821.70M | $755.19M |
Low Forecast | $1.90B | $1.42B | $1.45B | $1.52B | $1.64B | $1.30B | $1.30B | $1.37B | $1.55B | $1.14B | $1.15B | $813.37M | $1.37B | $1.15B | $1.24B | $739.43M | $1.26B | $1.49B | $1.55B | $584.53M | $1.35B | $1.42B | $1.35B | $1.16B | $1.24B | $896.46M | $719.99M | $462.08M | $821.70M | $755.19M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | - | 0.85% | 1.57% | 1.42% | 1.06% | 1.09% | 2.36% | 1.06% | 0.82% | 1.32% | 1.47% | 1.00% | 0.99% | 1.29% | 1.03% | 1.55% | 0.88% |
Forecast
Danaher SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 5 | 5 | 9 | 5 | 4 | 4 | 11 | 11 | 5 | 4 | 6 | 8 | 18 | 12 | 9 | 8 | 14 | 8 | 8 | 17 | 9 | 11 | 17 | 9 | 13 | 17 | 9 | 8 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $2.04B | - | $2.19B | $2.15B | $2.19B | $2.15B | $2.08B | $2.09B | $2.29B | $2.06B | $1.97B | $1.88B | $1.96B | $1.80B | $1.69B | $1.46B | $578.40M | $1.65B |
Avg Forecast | $2.14B | $1.87B | $1.88B | $1.86B | $2.00B | $1.75B | $1.75B | $1.74B | $1.90B | $1.65B | $1.65B | $2.49B | $1.81B | $1.94B | $2.10B | $2.26B | $2.02B | $2.11B | $2.15B | $1.79B | $2.16B | $2.06B | $1.98B | $1.85B | $1.94B | $1.62B | $1.46B | $1.42B | $1.41B | $1.48B |
High Forecast | $2.22B | $1.94B | $1.95B | $1.94B | $2.08B | $1.82B | $1.81B | $1.79B | $1.92B | $1.65B | $1.65B | $2.99B | $1.91B | $2.10B | $2.18B | $2.72B | $2.42B | $2.11B | $2.15B | $2.15B | $2.59B | $2.06B | $1.98B | $1.85B | $1.94B | $1.62B | $1.46B | $1.70B | $1.41B | $1.48B |
Low Forecast | $2.06B | $1.81B | $1.81B | $1.80B | $1.93B | $1.69B | $1.68B | $1.68B | $1.88B | $1.65B | $1.65B | $1.99B | $1.78B | $1.58B | $2.02B | $1.81B | $1.61B | $2.11B | $2.15B | $1.43B | $1.73B | $2.06B | $1.98B | $1.85B | $1.94B | $1.62B | $1.46B | $1.13B | $1.41B | $1.48B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | - | 1.05% | 0.95% | 1.09% | 1.02% | 0.97% | 1.17% | 1.06% | 1.00% | 0.99% | 1.01% | 1.01% | 1.11% | 1.16% | 1.03% | 0.41% | 1.12% |
Forecast
Danaher EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 5 | 5 | 9 | 5 | 4 | 4 | 11 | 11 | 5 | 4 | 6 | 8 | 18 | 12 | 9 | 8 | 14 | 8 | 8 | 17 | 9 | 11 | 17 | 9 | 13 | 17 | 9 | 8 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $1.45 | - | $1.50 | $1.96 | $3.03 | $2.13 | $2.28 | $2.35 | $2.50 | $1.56 | $2.44 | $2.33 | $1.69 | $1.18 | $1.27 | $0.83 | $1.75 | $0.90 |
Avg Forecast | $2.73 | $2.04 | $2.09 | $2.19 | $2.36 | $1.87 | $1.87 | $1.96 | $2.16 | $1.57 | $1.57 | $1.72 | $1.91 | $1.81 | $1.78 | $2.00 | $2.26 | $2.00 | $2.08 | $2.36 | $2.26 | $1.91 | $1.82 | $1.56 | $1.67 | $1.21 | $0.97 | $0.91 | $1.11 | $1.02 |
High Forecast | $2.87 | $2.14 | $2.20 | $2.30 | $2.48 | $1.96 | $1.97 | $2.09 | $2.20 | $1.57 | $1.57 | $1.72 | $2.00 | $2.07 | $1.87 | $2.10 | $2.32 | $2.00 | $2.08 | $2.36 | $2.26 | $1.91 | $1.82 | $1.56 | $1.67 | $1.21 | $0.97 | $0.91 | $1.11 | $1.02 |
Low Forecast | $2.60 | $1.95 | $1.99 | $2.09 | $2.25 | $1.78 | $1.79 | $1.88 | $2.13 | $1.57 | $1.57 | $1.72 | $1.87 | $1.58 | $1.70 | $1.91 | $2.16 | $2.00 | $2.08 | $2.36 | $2.26 | $1.91 | $1.82 | $1.56 | $1.67 | $1.21 | $0.97 | $0.91 | $1.11 | $1.02 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | - | 0.84% | 0.98% | 1.34% | 1.06% | 1.10% | 0.99% | 1.11% | 0.82% | 1.34% | 1.49% | 1.02% | 0.98% | 1.31% | 0.92% | 1.58% | 0.88% |
Forecast
Danaher Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
DHR | Danaher | $223.73 | $283.86 | 26.88% | Buy |
CRL | Charles River Laboratories | $161.64 | $201.50 | 24.66% | Buy |
IDXX | IDEXX Laboratories | $418.75 | $479.75 | 14.57% | Buy |
ILMN | Illumina | $131.72 | $150.00 | 13.88% | Buy |
TMO | Thermo Fisher Scientific | $568.23 | $631.71 | 11.17% | Buy |
RVTY | Revvity | $123.52 | $133.80 | 8.32% | Buy |
MTD | Mettler-Toledo | $1.34K | $1.41K | 5.77% | Hold |
A | Agilent | $147.09 | $150.50 | 2.32% | Buy |
WAT | Waters | $404.17 | $371.00 | -8.21% | Buy |
GH | Guardant Health | $47.65 | $39.00 | -18.15% | Buy |